Novel motif:103: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 15:05, 9 September 2013
name: | motif103_CGGCTAWWT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0090304 | nucleic acid metabolic process | 2.543609e-16 |
GO:0032774 | RNA biosynthetic process | 1.565633e-15 |
GO:0006351 | transcription, DNA-dependent | 5.202064e-15 |
GO:0016070 | RNA metabolic process | 2.252945e-13 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 7.723673e-13 |
GO:0010467 | gene expression | 1.638894e-12 |
GO:0034645 | cellular macromolecule biosynthetic process | 9.398832e-12 |
GO:0009059 | macromolecule biosynthetic process | 5.432259e-11 |
GO:0006139 | nucleobase-containing compound metabolic process | 5.283164e-10 |
GO:0034641 | cellular nitrogen compound metabolic process | 6.300595e-10 |
GO:0010468 | regulation of gene expression | 6.815122e-10 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 8.533025e-10 |
GO:0006807 | nitrogen compound metabolic process | 9.220636e-10 |
GO:0006355 | regulation of transcription, DNA-dependent | 2.193709e-9 |
GO:0051252 | regulation of RNA metabolic process | 2.782201e-9 |
GO:0071333 | cellular response to glucose stimulus | 7.696120e-9 |
GO:0001678 | cellular glucose homeostasis | 1.245457e-8 |
GO:0010556 | regulation of macromolecule biosynthetic process | 1.529219e-8 |
GO:0010628 | positive regulation of gene expression | 2.664246e-8 |
GO:0071322 | cellular response to carbohydrate stimulus | 2.767967e-8 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 3.023475e-8 |
GO:0044249 | cellular biosynthetic process | 5.302293e-8 |
GO:0072132 | mesenchyme morphogenesis | 5.316031e-8 |
GO:0009058 | biosynthetic process | 6.514579e-8 |
GO:0060056 | mammary gland involution | 7.596701e-8 |
GO:0010966 | regulation of phosphate transport | 1.770332e-7 |
GO:0031345 | negative regulation of cell projection organization | 2.457732e-7 |
GO:0060395 | SMAD protein signal transduction | 2.487253e-7 |
GO:0051254 | positive regulation of RNA metabolic process | 2.551172e-7 |
GO:0006695 | cholesterol biosynthetic process | 3.464066e-7 |
GO:0072234 | metanephric nephron tubule development | 4.223664e-7 |
GO:0072282 | metanephric nephron tubule morphogenesis | 5.321325e-7 |
GO:0072170 | metanephric tubule development | 6.060445e-7 |
GO:0045065 | cytotoxic T cell differentiation | 6.534067e-7 |
GO:0006600 | creatine metabolic process | 7.641803e-7 |
GO:0001945 | lymph vessel development | 1.223743e-6 |
GO:0051290 | protein heterotetramerization | 1.428216e-6 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 1.478580e-6 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.101991e-6 |
GO:0031326 | regulation of cellular biosynthetic process | 2.186580e-6 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 2.533595e-6 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 2.820389e-6 |
GO:0000082 | G1/S transition of mitotic cell cycle | 3.251446e-6 |
GO:0090086 | negative regulation of protein deubiquitination | 3.380699e-6 |
GO:0072148 | epithelial cell fate commitment | 3.486956e-6 |
GO:0072207 | metanephric epithelium development | 3.654303e-6 |
GO:0046314 | phosphocreatine biosynthetic process | 3.718385e-6 |
GO:0003188 | heart valve formation | 3.944262e-6 |
GO:0009889 | regulation of biosynthetic process | 3.986636e-6 |
GO:0045444 | fat cell differentiation | 4.361806e-6 |
GO:0060088 | auditory receptor cell stereocilium organization | 4.516835e-6 |
GO:0050771 | negative regulation of axonogenesis | 4.716349e-6 |
GO:0018027 | peptidyl-lysine dimethylation | 4.919513e-6 |
GO:0060376 | positive regulation of mast cell differentiation | 6.287844e-6 |
GO:0044260 | cellular macromolecule metabolic process | 6.486206e-6 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 6.519767e-6 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 6.547568e-6 |
GO:0060255 | regulation of macromolecule metabolic process | 6.882493e-6 |
GO:0022601 | menstrual cycle phase | 8.011988e-6 |
GO:0060375 | regulation of mast cell differentiation | 9.032706e-6 |
GO:0051329 | interphase of mitotic cell cycle | 1.045724e-5 |
GO:0035048 | splicing factor protein import into nucleus | 1.051835e-5 |
GO:0002093 | auditory receptor cell morphogenesis | 1.054496e-5 |
GO:0003197 | endocardial cushion development | 1.064565e-5 |
GO:0090085 | regulation of protein deubiquitination | 1.134999e-5 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 1.134999e-5 |
GO:0002092 | positive regulation of receptor internalization | 1.281970e-5 |
GO:0045606 | positive regulation of epidermal cell differentiation | 1.333851e-5 |
GO:0071569 | protein ufmylation | 1.415578e-5 |
GO:0035871 | protein K11-linked deubiquitination | 1.629089e-5 |
GO:0016126 | sterol biosynthetic process | 1.876768e-5 |
GO:0051325 | interphase | 1.972170e-5 |
GO:0043267 | negative regulation of potassium ion transport | 2.089875e-5 |
GO:0006281 | DNA repair | 2.173431e-5 |
GO:0006302 | double-strand break repair | 2.465021e-5 |
GO:0045922 | negative regulation of fatty acid metabolic process | 2.654129e-5 |
GO:0055062 | phosphate ion homeostasis | 2.704859e-5 |
GO:0021553 | olfactory nerve development | 2.868095e-5 |
GO:0045446 | endothelial cell differentiation | 3.148241e-5 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 3.188767e-5 |
GO:0006413 | translational initiation | 3.189132e-5 |
GO:0048562 | embryonic organ morphogenesis | 3.840818e-5 |
GO:0042396 | phosphagen biosynthetic process | 3.865052e-5 |
GO:0001839 | neural plate morphogenesis | 3.899423e-5 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.904720e-5 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 4.057214e-5 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 4.073233e-5 |
GO:0008333 | endosome to lysosome transport | 4.144164e-5 |
GO:0006974 | response to DNA damage stimulus | 4.192120e-5 |
GO:0006549 | isoleucine metabolic process | 4.413774e-5 |
GO:0060122 | inner ear receptor stereocilium organization | 4.515228e-5 |
GO:0090074 | negative regulation of protein homodimerization activity | 4.652820e-5 |
GO:0000578 | embryonic axis specification | 4.883772e-5 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 5.007230e-5 |
GO:0016055 | Wnt receptor signaling pathway | 5.383687e-5 |
GO:0072289 | metanephric nephron tubule formation | 5.467385e-5 |
GO:0007548 | sex differentiation | 5.488526e-5 |
GO:0042471 | ear morphogenesis | 5.559508e-5 |
GO:0042552 | myelination | 5.757440e-5 |
GO:0060839 | endothelial cell fate commitment | 6.217524e-5 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 6.313348e-5 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 6.377746e-5 |
GO:0048213 | Golgi vesicle prefusion complex stabilization | 6.377746e-5 |
GO:0015853 | adenine transport | 6.618847e-5 |
GO:0030967 | ER-nuclear sterol response pathway | 6.710095e-5 |
GO:0016575 | histone deacetylation | 6.899180e-5 |
GO:0001756 | somitogenesis | 7.021123e-5 |
GO:0090090 | negative regulation of canonical Wnt receptor signaling pathway | 7.437150e-5 |
GO:0014063 | negative regulation of serotonin secretion | 7.493166e-5 |
GO:0046479 | glycosphingolipid catabolic process | 7.614996e-5 |
GO:0030308 | negative regulation of cell growth | 7.778618e-5 |
GO:0051084 | 'de novo' posttranslational protein folding | 7.926078e-5 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 8.099228e-5 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 8.153594e-5 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 8.176695e-5 |
GO:0046415 | urate metabolic process | 8.218557e-5 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 8.312868e-5 |
GO:0051171 | regulation of nitrogen compound metabolic process | 8.986242e-5 |
GO:0060737 | prostate gland morphogenetic growth | 9.366014e-5 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 9.692650e-5 |
GO:0042472 | inner ear morphogenesis | 9.717840e-5 |
GO:0048343 | paraxial mesodermal cell fate commitment | 1.040183e-4 |
GO:0072189 | ureter development | 1.146337e-4 |
GO:0050768 | negative regulation of neurogenesis | 1.179143e-4 |
GO:0048568 | embryonic organ development | 1.234684e-4 |
GO:0090324 | negative regulation of oxidative phosphorylation | 1.237353e-4 |
GO:0010255 | glucose mediated signaling pathway | 1.237353e-4 |
GO:0007034 | vacuolar transport | 1.241322e-4 |
GO:0010991 | negative regulation of SMAD protein complex assembly | 1.249849e-4 |
GO:0019915 | lipid storage | 1.273983e-4 |
GO:0061136 | regulation of proteasomal protein catabolic process | 1.320457e-4 |
GO:0051320 | S phase | 1.388922e-4 |
GO:0003203 | endocardial cushion morphogenesis | 1.395264e-4 |
GO:0007041 | lysosomal transport | 1.473288e-4 |
GO:0071557 | histone H3-K27 demethylation | 1.476846e-4 |
GO:0035574 | histone H4-K20 demethylation | 1.476846e-4 |
GO:0018026 | peptidyl-lysine monomethylation | 1.483882e-4 |
GO:0001840 | neural plate development | 1.560335e-4 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 1.580404e-4 |
GO:0070682 | proteasome regulatory particle assembly | 1.641482e-4 |
GO:0021545 | cranial nerve development | 1.707164e-4 |
GO:0003158 | endothelium development | 1.753982e-4 |
GO:0009636 | response to toxin | 1.764393e-4 |
GO:0001514 | selenocysteine incorporation | 1.800731e-4 |
GO:0048846 | axon extension involved in axon guidance | 1.825390e-4 |
GO:0001656 | metanephros development | 1.896262e-4 |
GO:0030111 | regulation of Wnt receptor signaling pathway | 1.922722e-4 |
GO:0000084 | S phase of mitotic cell cycle | 1.924714e-4 |
GO:0007352 | zygotic specification of dorsal/ventral axis | 1.956609e-4 |
GO:0071479 | cellular response to ionizing radiation | 1.971748e-4 |
GO:0060485 | mesenchyme development | 2.037880e-4 |
GO:0006325 | chromatin organization | 2.062252e-4 |
GO:0031323 | regulation of cellular metabolic process | 2.063996e-4 |
GO:0007213 | muscarinic acetylcholine receptor signaling pathway | 2.089028e-4 |
GO:0003214 | cardiac left ventricle morphogenesis | 2.125203e-4 |
GO:0000185 | activation of MAPKKK activity | 2.125203e-4 |
GO:0030903 | notochord development | 2.148053e-4 |
GO:0008299 | isoprenoid biosynthetic process | 2.196163e-4 |
GO:0010950 | positive regulation of endopeptidase activity | 2.253283e-4 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 2.435287e-4 |
GO:0003338 | metanephros morphogenesis | 2.460316e-4 |
GO:0031129 | inductive cell-cell signaling | 2.467044e-4 |
GO:0072273 | metanephric nephron morphogenesis | 2.528945e-4 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 2.549045e-4 |
GO:0035622 | intrahepatic bile duct development | 2.619426e-4 |
GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis | 2.619426e-4 |
GO:0060784 | regulation of cell proliferation involved in tissue homeostasis | 2.619426e-4 |
GO:0060517 | epithelial cell proliferation involved in prostatic bud elongation | 2.619426e-4 |
GO:0003415 | chondrocyte hypertrophy | 2.619426e-4 |
GO:0014034 | neural crest cell fate commitment | 2.619426e-4 |
GO:0019100 | male germ-line sex determination | 2.619426e-4 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 2.716850e-4 |
GO:0003002 | regionalization | 2.788454e-4 |
GO:0006476 | protein deacetylation | 2.803325e-4 |
GO:0006458 | 'de novo' protein folding | 2.851310e-4 |
GO:0035282 | segmentation | 2.896595e-4 |
GO:0006333 | chromatin assembly or disassembly | 2.917232e-4 |
GO:0048333 | mesodermal cell differentiation | 3.061385e-4 |
GO:0051253 | negative regulation of RNA metabolic process | 3.066800e-4 |
GO:0000724 | double-strand break repair via homologous recombination | 3.067192e-4 |
GO:0008366 | axon ensheathment | 3.069443e-4 |
GO:0010756 | positive regulation of plasminogen activation | 3.175995e-4 |
GO:0006573 | valine metabolic process | 3.193779e-4 |
GO:0045926 | negative regulation of growth | 3.288010e-4 |
GO:0032825 | positive regulation of natural killer cell differentiation | 3.407706e-4 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 3.428482e-4 |
GO:0002082 | regulation of oxidative phosphorylation | 3.493497e-4 |
GO:0060628 | regulation of ER to Golgi vesicle-mediated transport | 3.493497e-4 |
GO:0000717 | nucleotide-excision repair, DNA duplex unwinding | 3.493497e-4 |
GO:0032200 | telomere organization | 3.584927e-4 |
GO:0035601 | protein deacylation | 3.597217e-4 |
GO:0030238 | male sex determination | 3.702633e-4 |
GO:0000725 | recombinational repair | 3.703808e-4 |
GO:0045665 | negative regulation of neuron differentiation | 3.798365e-4 |
GO:0060135 | maternal process involved in female pregnancy | 4.005691e-4 |
GO:0071922 | regulation of cohesin localization to chromatin | 4.034441e-4 |
GO:0060117 | auditory receptor cell development | 4.108855e-4 |
GO:0033598 | mammary gland epithelial cell proliferation | 4.200984e-4 |
GO:0070668 | positive regulation of mast cell proliferation | 4.226372e-4 |
GO:0044070 | regulation of anion transport | 4.259142e-4 |
GO:0030719 | P granule organization | 4.261417e-4 |
GO:0006259 | DNA metabolic process | 4.366033e-4 |
GO:0050686 | negative regulation of mRNA processing | 4.759424e-4 |
GO:0035459 | cargo loading into vesicle | 4.785746e-4 |
GO:0060644 | mammary gland epithelial cell differentiation | 4.827176e-4 |
GO:0060847 | endothelial cell fate specification | 5.017836e-4 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 5.131196e-4 |
GO:0031120 | snRNA pseudouridine synthesis | 5.326043e-4 |
GO:0060286 | flagellar cell motility | 5.326043e-4 |
GO:0016142 | O-glycoside catabolic process | 5.326043e-4 |
GO:0006037 | cell wall chitin metabolic process | 5.326043e-4 |
GO:0008595 | anterior/posterior axis specification, embryo | 5.683610e-4 |
GO:0043266 | regulation of potassium ion transport | 5.779852e-4 |
GO:0000086 | G2/M transition of mitotic cell cycle | 6.048859e-4 |
GO:0060221 | retinal rod cell differentiation | 6.335076e-4 |
GO:0048839 | inner ear development | 6.342562e-4 |
GO:0045299 | otolith mineralization | 6.346248e-4 |
GO:0045137 | development of primary sexual characteristics | 6.608236e-4 |
GO:0080090 | regulation of primary metabolic process | 6.775667e-4 |
GO:0009956 | radial pattern formation | 6.831128e-4 |
GO:0051276 | chromosome organization | 6.971056e-4 |
GO:0060014 | granulosa cell differentiation | 7.110217e-4 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 7.139157e-4 |
GO:0015680 | intracellular copper ion transport | 7.241863e-4 |
GO:0030178 | negative regulation of Wnt receptor signaling pathway | 7.284367e-4 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 7.406417e-4 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 7.559151e-4 |
GO:0010044 | response to aluminum ion | 7.560445e-4 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 7.573360e-4 |
GO:0045885 | positive regulation of survival gene product expression | 7.606814e-4 |
GO:0001661 | conditioned taste aversion | 7.711682e-4 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 7.751104e-4 |
GO:0033577 | protein glycosylation in endoplasmic reticulum | 7.751104e-4 |
GO:0009098 | leucine biosynthetic process | 7.751104e-4 |
GO:0006550 | isoleucine catabolic process | 7.751104e-4 |
GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development | 7.772627e-4 |
GO:0046544 | development of secondary male sexual characteristics | 7.772627e-4 |
GO:0072034 | renal vesicle induction | 8.352616e-4 |
GO:0021707 | cerebellar granule cell differentiation | 8.437184e-4 |
GO:0043170 | macromolecule metabolic process | 8.446825e-4 |
GO:0060446 | branching involved in open tracheal system development | 8.973633e-4 |
GO:0090131 | mesenchyme migration | 8.973633e-4 |
GO:0060461 | right lung morphogenesis | 8.973633e-4 |
GO:0014822 | detection of wounding | 8.973633e-4 |
GO:0048371 | lateral mesodermal cell differentiation | 8.973633e-4 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 8.973633e-4 |
GO:0007350 | blastoderm segmentation | 8.981467e-4 |
GO:0010923 | negative regulation of phosphatase activity | 9.156435e-4 |
GO:0021524 | visceral motor neuron differentiation | 9.224035e-4 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 9.501353e-4 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 9.753892e-4 |
GO:0033119 | negative regulation of RNA splicing | 9.770481e-4 |
GO:0061364 | apoptosis involved in luteolysis | 9.811300e-4 |
GO:0061053 | somite development | 9.829762e-4 |
GO:0018993 | somatic sex determination | 9.991666e-4 |
GO:0048370 | lateral mesoderm formation | 9.991666e-4 |
GO:0043271 | negative regulation of ion transport | 9.995064e-4 |
GO:0010721 | negative regulation of cell development | 1.003178e-3 |
GO:0008406 | gonad development | 1.017140e-3 |
GO:0000723 | telomere maintenance | 1.040908e-3 |
GO:0043583 | ear development | 1.054172e-3 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 1.080100e-3 |
GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process | 1.086301e-3 |
GO:0043534 | blood vessel endothelial cell migration | 1.091662e-3 |
GO:0042593 | glucose homeostasis | 1.099919e-3 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.128028e-3 |
GO:0048936 | peripheral nervous system neuron axonogenesis | 1.155345e-3 |
GO:0006313 | transposition, DNA-mediated | 1.155345e-3 |
GO:0031327 | negative regulation of cellular biosynthetic process | 1.182212e-3 |
GO:0051457 | maintenance of protein location in nucleus | 1.192653e-3 |
GO:0045862 | positive regulation of proteolysis | 1.195284e-3 |
GO:0019377 | glycolipid catabolic process | 1.212382e-3 |
GO:0002456 | T cell mediated immunity | 1.212382e-3 |
GO:0016139 | glycoside catabolic process | 1.223290e-3 |
GO:0033205 | cell cycle cytokinesis | 1.263219e-3 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 1.269012e-3 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 1.288520e-3 |
GO:0072009 | nephron epithelium development | 1.292247e-3 |
GO:0032235 | negative regulation of calcium ion transport via store-operated calcium channel activity | 1.301266e-3 |
GO:0072073 | kidney epithelium development | 1.328294e-3 |
GO:0060745 | mammary gland branching involved in pregnancy | 1.338755e-3 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 1.354480e-3 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.364353e-3 |
GO:0007072 | positive regulation of transcription on exit from mitosis | 1.413443e-3 |
GO:0006747 | FAD biosynthetic process | 1.413443e-3 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 1.430812e-3 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 1.456475e-3 |
GO:0001675 | acrosome assembly | 1.456475e-3 |
GO:0048386 | positive regulation of retinoic acid receptor signaling pathway | 1.491230e-3 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 1.507242e-3 |
GO:0055081 | anion homeostasis | 1.510383e-3 |
GO:0060042 | retina morphogenesis in camera-type eye | 1.526295e-3 |
GO:0042703 | menstruation | 1.530254e-3 |
GO:0019101 | female somatic sex determination | 1.530254e-3 |
GO:0009057 | macromolecule catabolic process | 1.533646e-3 |
GO:0072078 | nephron tubule morphogenesis | 1.544360e-3 |
GO:0042491 | auditory receptor cell differentiation | 1.552104e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 1.562187e-3 |
GO:0048339 | paraxial mesoderm development | 1.647452e-3 |
GO:0007538 | primary sex determination | 1.651304e-3 |
GO:0031497 | chromatin assembly | 1.664929e-3 |
GO:0018022 | peptidyl-lysine methylation | 1.698770e-3 |
GO:0071504 | cellular response to heparin | 1.698770e-3 |
GO:0030514 | negative regulation of BMP signaling pathway | 1.747036e-3 |
GO:0060749 | mammary gland alveolus development | 1.779590e-3 |
GO:0006334 | nucleosome assembly | 1.793778e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.813056e-3 |
GO:0043249 | erythrocyte maturation | 1.816163e-3 |
GO:0006744 | ubiquinone biosynthetic process | 1.816163e-3 |
GO:0019530 | taurine metabolic process | 1.818093e-3 |
GO:0014029 | neural crest formation | 1.818093e-3 |
GO:0072080 | nephron tubule development | 1.860615e-3 |
GO:0009890 | negative regulation of biosynthetic process | 1.862088e-3 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 1.889605e-3 |
GO:0035089 | establishment of apical/basal cell polarity | 1.902795e-3 |
GO:0072088 | nephron epithelium morphogenesis | 1.913922e-3 |
GO:0048588 | developmental cell growth | 1.937303e-3 |
GO:0048368 | lateral mesoderm development | 1.940171e-3 |
GO:0032910 | regulation of transforming growth factor beta3 production | 1.940171e-3 |
GO:0046940 | nucleoside monophosphate phosphorylation | 1.952554e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.978805e-3 |
GO:0006344 | maintenance of chromatin silencing | 1.981130e-3 |
GO:0071786 | endoplasmic reticulum tubular network organization | 1.998075e-3 |
GO:0035385 | Roundabout signaling pathway | 1.998075e-3 |
GO:0060426 | lung vasculature development | 2.012168e-3 |
GO:0051298 | centrosome duplication | 2.030030e-3 |
GO:0031324 | negative regulation of cellular metabolic process | 2.054338e-3 |
GO:0003407 | neural retina development | 2.054484e-3 |
GO:0001843 | neural tube closure | 2.068906e-3 |
GO:0070934 | CRD-mediated mRNA stabilization | 2.069628e-3 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 2.078755e-3 |
GO:0048598 | embryonic morphogenesis | 2.084622e-3 |
GO:0070544 | histone H3-K36 demethylation | 2.147744e-3 |
GO:0010092 | specification of organ identity | 2.194219e-3 |
GO:0009313 | oligosaccharide catabolic process | 2.200339e-3 |
GO:0000077 | DNA damage checkpoint | 2.233332e-3 |
GO:0006991 | response to sterol depletion | 2.238285e-3 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 2.238285e-3 |
GO:0072668 | tubulin complex biogenesis | 2.266054e-3 |
GO:0071503 | response to heparin | 2.354701e-3 |
GO:0045426 | quinone cofactor biosynthetic process | 2.354701e-3 |
GO:0042375 | quinone cofactor metabolic process | 2.363270e-3 |
GO:0006304 | DNA modification | 2.387039e-3 |
GO:0033026 | negative regulation of mast cell apoptosis | 2.396892e-3 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 2.403009e-3 |
GO:0003017 | lymph circulation | 2.403009e-3 |
GO:0010629 | negative regulation of gene expression | 2.418675e-3 |
GO:0031987 | locomotion involved in locomotory behavior | 2.438893e-3 |
GO:0021675 | nerve development | 2.439102e-3 |
GO:0060606 | tube closure | 2.499649e-3 |
GO:0030237 | female sex determination | 2.558940e-3 |
GO:0006430 | lysyl-tRNA aminoacylation | 2.580316e-3 |
GO:0006689 | ganglioside catabolic process | 2.624568e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 2.654799e-3 |
GO:0050770 | regulation of axonogenesis | 2.661995e-3 |
GO:0009952 | anterior/posterior pattern specification | 2.665682e-3 |
GO:0002074 | extraocular skeletal muscle development | 2.763840e-3 |
GO:0060119 | inner ear receptor cell development | 2.776727e-3 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.826364e-3 |
GO:0021681 | cerebellar granular layer development | 2.834175e-3 |
GO:0006863 | purine base transport | 2.864174e-3 |
GO:0060729 | intestinal epithelial structure maintenance | 2.864806e-3 |
GO:0045198 | establishment of epithelial cell apical/basal polarity | 2.871101e-3 |
GO:0014020 | primary neural tube formation | 2.957493e-3 |
GO:0061326 | renal tubule development | 2.965288e-3 |
GO:0031328 | positive regulation of cellular biosynthetic process | 3.092928e-3 |
GO:0006363 | termination of RNA polymerase I transcription | 3.160738e-3 |
GO:0008089 | anterograde axon cargo transport | 3.161019e-3 |
GO:0031570 | DNA integrity checkpoint | 3.164965e-3 |
GO:0044265 | cellular macromolecule catabolic process | 3.167844e-3 |
GO:0051097 | negative regulation of helicase activity | 3.205883e-3 |
GO:0044273 | sulfur compound catabolic process | 3.211592e-3 |
GO:0033238 | regulation of cellular amine metabolic process | 3.264246e-3 |
GO:0045408 | regulation of interleukin-6 biosynthetic process | 3.302291e-3 |
GO:0010634 | positive regulation of epithelial cell migration | 3.302291e-3 |
GO:0060463 | lung lobe morphogenesis | 3.362172e-3 |
GO:0006542 | glutamine biosynthetic process | 3.397186e-3 |
GO:0060841 | venous blood vessel development | 3.497325e-3 |
GO:0060914 | heart formation | 3.555624e-3 |
GO:0043060 | meiotic metaphase I plate congression | 3.575779e-3 |
GO:2000438 | negative regulation of monocyte extravasation | 3.575779e-3 |
GO:0080154 | regulation of fertilization | 3.575779e-3 |
GO:0035724 | CD24 biosynthetic process | 3.575779e-3 |
GO:0035723 | interleukin-15-mediated signaling pathway | 3.575779e-3 |
GO:0015684 | ferrous iron transport | 3.575779e-3 |
GO:0018205 | peptidyl-lysine modification | 3.580632e-3 |
GO:0048205 | COPI coating of Golgi vesicle | 3.608696e-3 |
GO:0030033 | microvillus assembly | 3.608696e-3 |
GO:0032933 | SREBP-mediated signaling pathway | 3.726055e-3 |
GO:0034213 | quinolinate catabolic process | 3.762442e-3 |
GO:0019439 | aromatic compound catabolic process | 3.777822e-3 |
GO:0072028 | nephron morphogenesis | 3.847875e-3 |
GO:0071108 | protein K48-linked deubiquitination | 3.902716e-3 |
GO:0048340 | paraxial mesoderm morphogenesis | 3.918452e-3 |
GO:0046449 | creatinine metabolic process | 3.947584e-3 |
GO:0016140 | O-glycoside metabolic process | 4.000095e-3 |
GO:0070100 | negative regulation of chemokine-mediated signaling pathway | 4.004307e-3 |
GO:0019941 | modification-dependent protein catabolic process | 4.023670e-3 |
GO:0010604 | positive regulation of macromolecule metabolic process | 4.064009e-3 |
GO:0090102 | cochlea development | 4.132063e-3 |
GO:0090162 | establishment of epithelial cell polarity | 4.163204e-3 |
GO:0060113 | inner ear receptor cell differentiation | 4.231173e-3 |
GO:0034616 | response to laminar fluid shear stress | 4.239541e-3 |
GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 4.301382e-3 |
GO:0006825 | copper ion transport | 4.301382e-3 |
GO:0061034 | olfactory bulb mitral cell layer development | 4.320753e-3 |
GO:0016568 | chromatin modification | 4.466671e-3 |
GO:0061180 | mammary gland epithelium development | 4.498484e-3 |
GO:0001553 | luteinization | 4.564920e-3 |
GO:0006521 | regulation of cellular amino acid metabolic process | 4.589203e-3 |
GO:0030070 | insulin processing | 4.623001e-3 |
GO:0051310 | metaphase plate congression | 4.689789e-3 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 4.720452e-3 |
GO:0021683 | cerebellar granular layer morphogenesis | 4.799444e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 4.800691e-3 |
GO:0006729 | tetrahydrobiopterin biosynthetic process | 4.800691e-3 |
GO:0021983 | pituitary gland development | 4.827151e-3 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 4.905211e-3 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 4.908042e-3 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 5.042528e-3 |
GO:0009074 | aromatic amino acid family catabolic process | 5.046005e-3 |
GO:0006686 | sphingomyelin biosynthetic process | 5.070179e-3 |
GO:0060018 | astrocyte fate commitment | 5.070179e-3 |
GO:0072210 | metanephric nephron development | 5.087260e-3 |
GO:0050673 | epithelial cell proliferation | 5.172302e-3 |
GO:0046618 | drug export | 5.225196e-3 |
GO:0045596 | negative regulation of cell differentiation | 5.239382e-3 |
GO:0040008 | regulation of growth | 5.244471e-3 |
GO:0035264 | multicellular organism growth | 5.368784e-3 |
GO:0033147 | negative regulation of estrogen receptor signaling pathway | 5.396496e-3 |
GO:0046827 | positive regulation of protein export from nucleus | 5.418778e-3 |
GO:0060011 | Sertoli cell proliferation | 5.425188e-3 |
GO:0019222 | regulation of metabolic process | 5.454726e-3 |
GO:0046533 | negative regulation of photoreceptor cell differentiation | 5.512354e-3 |
GO:0016137 | glycoside metabolic process | 5.512354e-3 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 5.548024e-3 |
GO:0061301 | cerebellum vasculature morphogenesis | 5.632241e-3 |
GO:0048352 | paraxial mesoderm structural organization | 5.632241e-3 |
GO:0045964 | positive regulation of dopamine metabolic process | 5.632241e-3 |
GO:0021998 | neural plate mediolateral regionalization | 5.632241e-3 |
GO:0048194 | Golgi vesicle budding | 5.653249e-3 |
GO:0009072 | aromatic amino acid family metabolic process | 5.668034e-3 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5.676304e-3 |
GO:0030879 | mammary gland development | 5.698730e-3 |
GO:0034728 | nucleosome organization | 5.700645e-3 |
GO:0003382 | epithelial cell morphogenesis | 5.705451e-3 |
GO:0009790 | embryo development | 5.715191e-3 |
GO:0030431 | sleep | 5.847386e-3 |
GO:0072092 | ureteric bud invasion | 5.894581e-3 |
GO:0035426 | extracellular matrix-cell signaling | 5.941728e-3 |
GO:0001885 | endothelial cell development | 5.943647e-3 |
GO:0010212 | response to ionizing radiation | 5.976192e-3 |
GO:0033261 | regulation of S phase | 6.048261e-3 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 6.079944e-3 |
GO:0060535 | trachea cartilage morphogenesis | 6.090752e-3 |
GO:0002268 | follicular dendritic cell differentiation | 6.090752e-3 |
GO:0045636 | positive regulation of melanocyte differentiation | 6.234187e-3 |
GO:0016584 | nucleosome positioning | 6.343657e-3 |
GO:0042737 | drug catabolic process | 6.343657e-3 |
GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 6.343657e-3 |
GO:0006533 | aspartate catabolic process | 6.471658e-3 |
GO:0070886 | positive regulation of calcineurin-NFAT signaling pathway | 6.525281e-3 |
GO:0009891 | positive regulation of biosynthetic process | 6.604905e-3 |
GO:0045634 | regulation of melanocyte differentiation | 6.613638e-3 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.619636e-3 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 6.680095e-3 |
GO:0007498 | mesoderm development | 6.683234e-3 |
GO:0051412 | response to corticosterone stimulus | 6.683619e-3 |
GO:0060290 | transdifferentiation | 6.731259e-3 |
GO:0006457 | protein folding | 6.755414e-3 |
GO:0051403 | stress-activated MAPK cascade | 6.786229e-3 |
GO:0009948 | anterior/posterior axis specification | 6.786404e-3 |
GO:0010870 | positive regulation of receptor biosynthetic process | 6.872923e-3 |
GO:0031441 | negative regulation of mRNA 3'-end processing | 6.984918e-3 |
GO:0009798 | axis specification | 7.007913e-3 |
GO:0065004 | protein-DNA complex assembly | 7.101985e-3 |
GO:0060084 | synaptic transmission involved in micturition | 7.152551e-3 |
GO:0050783 | cocaine metabolic process | 7.152551e-3 |
GO:0007207 | activation of phospholipase C activity by muscarinic acetylcholine receptor signaling pathway | 7.159167e-3 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 7.259604e-3 |
GO:0040038 | polar body extrusion after meiotic divisions | 7.269745e-3 |
GO:0072197 | ureter morphogenesis | 7.320190e-3 |
GO:0060897 | neural plate regionalization | 7.341697e-3 |
GO:0033169 | histone H3-K9 demethylation | 7.341697e-3 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 7.394942e-3 |
GO:0033555 | multicellular organismal response to stress | 7.457666e-3 |
GO:0045879 | negative regulation of smoothened signaling pathway | 7.477230e-3 |
GO:0048880 | sensory system development | 7.591080e-3 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 7.672130e-3 |
GO:0021801 | cerebral cortex radial glia guided migration | 7.722795e-3 |
GO:0048554 | positive regulation of metalloenzyme activity | 7.743542e-3 |
GO:0051297 | centrosome organization | 7.798939e-3 |
GO:0006516 | glycoprotein catabolic process | 7.807041e-3 |
GO:0030855 | epithelial cell differentiation | 7.834102e-3 |
GO:0061333 | renal tubule morphogenesis | 7.888315e-3 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 7.955794e-3 |
GO:0060041 | retina development in camera-type eye | 7.973471e-3 |
GO:0031325 | positive regulation of cellular metabolic process | 7.978844e-3 |
GO:0009649 | entrainment of circadian clock | 7.991288e-3 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 8.119319e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0060299 | negative regulation of sarcomere organization | 2.794852e-10 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 2.794852e-10 |
GO:0070925 | organelle assembly | 4.660084e-10 |
GO:0006975 | DNA damage induced protein phosphorylation | 2.508045e-9 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1.988816e-8 |
GO:0072355 | histone H3-T3 phosphorylation | 2.957493e-8 |
GO:0090086 | negative regulation of protein deubiquitination | 6.357251e-8 |
GO:0017158 | regulation of calcium ion-dependent exocytosis | 1.043486e-7 |
GO:0072075 | metanephric mesenchyme development | 1.236271e-7 |
GO:0045056 | transcytosis | 1.879016e-7 |
GO:0000045 | autophagic vacuole assembly | 2.290644e-7 |
GO:0071459 | protein localization to chromosome, centromeric region | 2.878004e-7 |
GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 4.487744e-7 |
GO:0016068 | type I hypersensitivity | 4.487744e-7 |
GO:0006986 | response to unfolded protein | 5.089835e-7 |
GO:0001822 | kidney development | 6.566282e-7 |
GO:0071670 | smooth muscle cell chemotaxis | 8.728631e-7 |
GO:0060981 | cell migration involved in coronary angiogenesis | 8.728631e-7 |
GO:0006713 | glucocorticoid catabolic process | 8.728631e-7 |
GO:0007099 | centriole replication | 1.023614e-6 |
GO:0030505 | inorganic diphosphate transport | 1.073711e-6 |
GO:0051932 | synaptic transmission, GABAergic | 1.077671e-6 |
GO:0006756 | AMP phosphorylation | 1.576474e-6 |
GO:0030433 | ER-associated protein catabolic process | 1.644522e-6 |
GO:0010519 | negative regulation of phospholipase activity | 1.924483e-6 |
GO:0010467 | gene expression | 2.016188e-6 |
GO:0072074 | kidney mesenchyme development | 2.045556e-6 |
GO:0008208 | C21-steroid hormone catabolic process | 2.683045e-6 |
GO:0090084 | negative regulation of inclusion body assembly | 2.705728e-6 |
GO:0090085 | regulation of protein deubiquitination | 2.705728e-6 |
GO:0001656 | metanephros development | 2.956101e-6 |
GO:0072001 | renal system development | 3.387552e-6 |
GO:0015705 | iodide transport | 3.584974e-6 |
GO:0072239 | metanephric glomerulus vasculature development | 3.634431e-6 |
GO:0035966 | response to topologically incorrect protein | 4.124002e-6 |
GO:0046940 | nucleoside monophosphate phosphorylation | 4.348976e-6 |
GO:0009948 | anterior/posterior axis specification | 5.121127e-6 |
GO:0016236 | macroautophagy | 6.205016e-6 |
GO:0072203 | cell proliferation involved in metanephros development | 6.434216e-6 |
GO:0072172 | mesonephric tubule formation | 6.913317e-6 |
GO:0051204 | protein insertion into mitochondrial membrane | 9.912944e-6 |
GO:0007498 | mesoderm development | 1.046639e-5 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.083795e-5 |
GO:0032863 | activation of Rac GTPase activity | 1.109939e-5 |
GO:0032232 | negative regulation of actin filament bundle assembly | 1.196383e-5 |
GO:0033566 | gamma-tubulin complex localization | 1.362243e-5 |
GO:0072183 | negative regulation of nephron tubule epithelial cell differentiation | 1.483989e-5 |
GO:0006011 | UDP-glucose metabolic process | 1.483989e-5 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 1.534345e-5 |
GO:0072012 | glomerulus vasculature development | 1.571766e-5 |
GO:0072109 | glomerular mesangium development | 1.898733e-5 |
GO:0010457 | centriole-centriole cohesion | 1.934007e-5 |
GO:0003100 | regulation of systemic arterial blood pressure by endothelin | 2.343337e-5 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 2.910168e-5 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 3.002853e-5 |
GO:0070301 | cellular response to hydrogen peroxide | 3.048606e-5 |
GO:0016070 | RNA metabolic process | 3.125591e-5 |
GO:0023061 | signal release | 3.276709e-5 |
GO:0010637 | negative regulation of mitochondrial fusion | 3.346057e-5 |
GO:0071279 | cellular response to cobalt ion | 3.346057e-5 |
GO:0007269 | neurotransmitter secretion | 3.491968e-5 |
GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 3.528143e-5 |
GO:0045116 | protein neddylation | 3.534952e-5 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 3.534952e-5 |
GO:0007023 | post-chaperonin tubulin folding pathway | 3.594975e-5 |
GO:0090083 | regulation of inclusion body assembly | 3.903978e-5 |
GO:0032682 | negative regulation of chemokine production | 3.991312e-5 |
GO:0090218 | positive regulation of lipid kinase activity | 4.217097e-5 |
GO:0072111 | cell proliferation involved in kidney development | 4.271731e-5 |
GO:0072143 | mesangial cell development | 4.568314e-5 |
GO:0072224 | metanephric glomerulus development | 4.619773e-5 |
GO:0010001 | glial cell differentiation | 4.706759e-5 |
GO:0031023 | microtubule organizing center organization | 4.925064e-5 |
GO:0090304 | nucleic acid metabolic process | 5.182577e-5 |
GO:0006930 | substrate-dependent cell migration, cell extension | 5.443126e-5 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 6.116776e-5 |
GO:0032940 | secretion by cell | 6.434256e-5 |
GO:0072171 | mesonephric tubule morphogenesis | 6.553699e-5 |
GO:0009059 | macromolecule biosynthetic process | 6.596311e-5 |
GO:0019858 | cytosine metabolic process | 6.797130e-5 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 7.024776e-5 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 7.341554e-5 |
GO:0051297 | centrosome organization | 8.118596e-5 |
GO:0031133 | regulation of axon diameter | 8.119343e-5 |
GO:0018279 | protein N-linked glycosylation via asparagine | 8.197125e-5 |
GO:0072162 | metanephric mesenchymal cell differentiation | 8.587027e-5 |
GO:0071480 | cellular response to gamma radiation | 9.178779e-5 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 9.499360e-5 |
GO:0031077 | post-embryonic camera-type eye development | 9.588036e-5 |
GO:0048793 | pronephros development | 1.035298e-4 |
GO:0045687 | positive regulation of glial cell differentiation | 1.065191e-4 |
GO:0072277 | metanephric glomerular capillary formation | 1.092274e-4 |
GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein | 1.125201e-4 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 1.125201e-4 |
GO:0034614 | cellular response to reactive oxygen species | 1.186733e-4 |
GO:0070625 | zymogen granule exocytosis | 1.192107e-4 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 1.192107e-4 |
GO:0048240 | sperm capacitation | 1.202198e-4 |
GO:0006661 | phosphatidylinositol biosynthetic process | 1.218397e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.248040e-4 |
GO:0046474 | glycerophospholipid biosynthetic process | 1.249568e-4 |
GO:0035282 | segmentation | 1.275984e-4 |
GO:0003334 | keratinocyte development | 1.289163e-4 |
GO:0042501 | serine phosphorylation of STAT protein | 1.318272e-4 |
GO:0018106 | peptidyl-histidine phosphorylation | 1.379786e-4 |
GO:0042063 | gliogenesis | 1.444499e-4 |
GO:0045665 | negative regulation of neuron differentiation | 1.504571e-4 |
GO:0048627 | myoblast development | 1.551651e-4 |
GO:0019255 | glucose 1-phosphate metabolic process | 1.580742e-4 |
GO:0032536 | regulation of cell projection size | 1.640278e-4 |
GO:0014909 | smooth muscle cell migration | 1.844208e-4 |
GO:0035441 | cell migration involved in vasculogenesis | 1.844208e-4 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1.854148e-4 |
GO:0032910 | regulation of transforming growth factor beta3 production | 1.854210e-4 |
GO:0006351 | transcription, DNA-dependent | 1.861297e-4 |
GO:0045662 | negative regulation of myoblast differentiation | 1.923909e-4 |
GO:0072259 | metanephric interstitial cell development | 1.935949e-4 |
GO:0072208 | metanephric smooth muscle tissue development | 1.935949e-4 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 1.935949e-4 |
GO:0072168 | specification of anterior mesonephric tubule identity | 1.935949e-4 |
GO:0072169 | specification of posterior mesonephric tubule identity | 1.935949e-4 |
GO:0072184 | renal vesicle progenitor cell differentiation | 1.935949e-4 |
GO:0061298 | retina vasculature development in camera-type eye | 2.040067e-4 |
GO:0032774 | RNA biosynthetic process | 2.082127e-4 |
GO:0048569 | post-embryonic organ development | 2.112643e-4 |
GO:0017156 | calcium ion-dependent exocytosis | 2.154146e-4 |
GO:0060459 | left lung development | 2.232381e-4 |
GO:0014812 | muscle cell migration | 2.272239e-4 |
GO:0048859 | formation of anatomical boundary | 2.283265e-4 |
GO:0006603 | phosphocreatine metabolic process | 2.283265e-4 |
GO:0043065 | positive regulation of apoptosis | 2.478735e-4 |
GO:0008360 | regulation of cell shape | 2.526302e-4 |
GO:0042921 | glucocorticoid receptor signaling pathway | 2.548085e-4 |
GO:0007501 | mesodermal cell fate specification | 2.621320e-4 |
GO:0016044 | cellular membrane organization | 2.749706e-4 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 2.762940e-4 |
GO:0043550 | regulation of lipid kinase activity | 2.783102e-4 |
GO:0061024 | membrane organization | 2.963805e-4 |
GO:0002355 | detection of tumor cell | 2.964362e-4 |
GO:0046488 | phosphatidylinositol metabolic process | 3.130721e-4 |
GO:0071874 | cellular response to norepinephrine stimulus | 3.206322e-4 |
GO:0030878 | thyroid gland development | 3.237145e-4 |
GO:0070830 | tight junction assembly | 3.266751e-4 |
GO:0060046 | regulation of acrosome reaction | 3.294677e-4 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 3.318124e-4 |
GO:0032495 | response to muramyl dipeptide | 3.318124e-4 |
GO:0060978 | angiogenesis involved in coronary vascular morphogenesis | 3.405514e-4 |
GO:0044260 | cellular macromolecule metabolic process | 3.408801e-4 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 3.541530e-4 |
GO:0072182 | regulation of nephron tubule epithelial cell differentiation | 3.583590e-4 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 3.599205e-4 |
GO:0035284 | brain segmentation | 3.599205e-4 |
GO:0034111 | negative regulation of homotypic cell-cell adhesion | 3.599205e-4 |
GO:0007256 | activation of JNKK activity | 3.760145e-4 |
GO:0032956 | regulation of actin cytoskeleton organization | 3.813808e-4 |
GO:0043068 | positive regulation of programmed cell death | 3.877721e-4 |
GO:0045213 | neurotransmitter receptor metabolic process | 3.910451e-4 |
GO:0045727 | positive regulation of translation | 4.011201e-4 |
GO:0008595 | anterior/posterior axis specification, embryo | 4.048036e-4 |
GO:0002347 | response to tumor cell | 4.108086e-4 |
GO:0090399 | replicative senescence | 4.139590e-4 |
GO:0035115 | embryonic forelimb morphogenesis | 4.144767e-4 |
GO:0016925 | protein sumoylation | 4.184708e-4 |
GO:0017157 | regulation of exocytosis | 4.199833e-4 |
GO:0048522 | positive regulation of cellular process | 4.247274e-4 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 4.332897e-4 |
GO:0002826 | negative regulation of T-helper 1 type immune response | 4.332897e-4 |
GO:0000073 | spindle pole body separation | 4.332897e-4 |
GO:0051298 | centrosome duplication | 4.485930e-4 |
GO:0007379 | segment specification | 4.495677e-4 |
GO:0006338 | chromatin remodeling | 4.550797e-4 |
GO:0032855 | positive regulation of Rac GTPase activity | 4.556956e-4 |
GO:0021660 | rhombomere 3 formation | 4.582180e-4 |
GO:0021666 | rhombomere 5 formation | 4.582180e-4 |
GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis | 4.675518e-4 |
GO:2000791 | negative regulation of mesenchymal cell proliferation involved in lung development | 4.675518e-4 |
GO:0021740 | principal sensory nucleus of trigeminal nerve development | 4.675518e-4 |
GO:0061141 | lung ciliated cell differentiation | 4.675518e-4 |
GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 4.675518e-4 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 4.833495e-4 |
GO:0021658 | rhombomere 3 morphogenesis | 4.918804e-4 |
GO:0007064 | mitotic sister chromatid cohesion | 4.994295e-4 |
GO:0072189 | ureter development | 5.226772e-4 |
GO:0051205 | protein insertion into membrane | 5.226772e-4 |
GO:0032970 | regulation of actin filament-based process | 5.232558e-4 |
GO:0000578 | embryonic axis specification | 5.262405e-4 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 5.271611e-4 |
GO:0018105 | peptidyl-serine phosphorylation | 5.333826e-4 |
GO:0007229 | integrin-mediated signaling pathway | 5.354776e-4 |
GO:0022604 | regulation of cell morphogenesis | 5.383644e-4 |
GO:0072079 | nephron tubule formation | 5.592065e-4 |
GO:0043631 | RNA polyadenylation | 5.726117e-4 |
GO:0046501 | protoporphyrinogen IX metabolic process | 5.772879e-4 |
GO:0048532 | anatomical structure arrangement | 6.025262e-4 |
GO:0045017 | glycerolipid biosynthetic process | 6.121596e-4 |
GO:0009798 | axis specification | 6.234692e-4 |
GO:0003167 | atrioventricular bundle cell differentiation | 6.383347e-4 |
GO:0060931 | sinoatrial node cell development | 6.383347e-4 |
GO:0042981 | regulation of apoptosis | 6.787215e-4 |
GO:0032902 | nerve growth factor production | 6.909427e-4 |
GO:0002331 | pre-B cell allelic exclusion | 6.909427e-4 |
GO:0000186 | activation of MAPKK activity | 7.002365e-4 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 7.074198e-4 |
GO:0009880 | embryonic pattern specification | 7.108464e-4 |
GO:0072133 | metanephric mesenchyme morphogenesis | 7.181324e-4 |
GO:0072006 | nephron development | 7.273011e-4 |
GO:0001710 | mesodermal cell fate commitment | 7.540336e-4 |
GO:0043067 | regulation of programmed cell death | 7.868035e-4 |
GO:2000573 | positive regulation of DNA biosynthetic process | 8.112976e-4 |
GO:0090185 | negative regulation of kidney development | 8.112976e-4 |
GO:0015760 | glucose-6-phosphate transport | 8.112976e-4 |
GO:0042044 | fluid transport | 8.287183e-4 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 8.300535e-4 |
GO:0050774 | negative regulation of dendrite morphogenesis | 8.303024e-4 |
GO:0060012 | synaptic transmission, glycinergic | 8.320669e-4 |
GO:0046103 | inosine biosynthetic process | 8.320669e-4 |
GO:0006154 | adenosine catabolic process | 8.320669e-4 |
GO:0032769 | negative regulation of monooxygenase activity | 8.327900e-4 |
GO:0048524 | positive regulation of viral reproduction | 8.485087e-4 |
GO:0060236 | regulation of mitotic spindle organization | 8.831392e-4 |
GO:0010991 | negative regulation of SMAD protein complex assembly | 8.831392e-4 |
GO:0048332 | mesoderm morphogenesis | 8.931225e-4 |
GO:0021700 | developmental maturation | 9.194567e-4 |
GO:0060326 | cell chemotaxis | 9.211895e-4 |
GO:0046887 | positive regulation of hormone secretion | 9.245273e-4 |
GO:0016572 | histone phosphorylation | 9.404333e-4 |
GO:0045792 | negative regulation of cell size | 9.419760e-4 |
GO:0014826 | vein smooth muscle contraction | 9.419760e-4 |
GO:0090183 | regulation of kidney development | 9.462457e-4 |
GO:0014015 | positive regulation of gliogenesis | 9.532583e-4 |
GO:0032535 | regulation of cellular component size | 1.012321e-3 |
GO:0006506 | GPI anchor biosynthetic process | 1.012411e-3 |
GO:0072081 | specification of nephron tubule identity | 1.026720e-3 |
GO:0001780 | neutrophil homeostasis | 1.026720e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 1.030481e-3 |
GO:0019358 | nicotinate nucleotide salvage | 1.062259e-3 |
GO:0021831 | embryonic olfactory bulb interneuron precursor migration | 1.062259e-3 |
GO:0010085 | polarity specification of proximal/distal axis | 1.062259e-3 |
GO:0006409 | tRNA export from nucleus | 1.062259e-3 |
GO:0010822 | positive regulation of mitochondrion organization | 1.065330e-3 |
GO:0033205 | cell cycle cytokinesis | 1.098429e-3 |
GO:0090197 | positive regulation of chemokine secretion | 1.099924e-3 |
GO:0051225 | spindle assembly | 1.208062e-3 |
GO:0051354 | negative regulation of oxidoreductase activity | 1.268289e-3 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.270836e-3 |
GO:0006086 | acetyl-CoA biosynthetic process from pyruvate | 1.270836e-3 |
GO:0072202 | cell differentiation involved in metanephros development | 1.271674e-3 |
GO:0021773 | striatal medium spiny neuron differentiation | 1.310918e-3 |
GO:0060921 | sinoatrial node cell differentiation | 1.349155e-3 |
GO:0051252 | regulation of RNA metabolic process | 1.357882e-3 |
GO:0046486 | glycerolipid metabolic process | 1.361589e-3 |
GO:0010941 | regulation of cell death | 1.377994e-3 |
GO:0018193 | peptidyl-amino acid modification | 1.385973e-3 |
GO:0008630 | DNA damage response, signal transduction resulting in induction of apoptosis | 1.387038e-3 |
GO:0007097 | nuclear migration | 1.428880e-3 |
GO:0046102 | inosine metabolic process | 1.436810e-3 |
GO:0006931 | substrate-dependent cell migration, cell attachment to substrate | 1.436810e-3 |
GO:0045109 | intermediate filament organization | 1.446007e-3 |
GO:0007109 | cytokinesis, completion of separation | 1.461308e-3 |
GO:0050892 | intestinal absorption | 1.462231e-3 |
GO:0072164 | mesonephric tubule development | 1.476519e-3 |
GO:0031958 | corticosteroid receptor signaling pathway | 1.476519e-3 |
GO:0003002 | regionalization | 1.483773e-3 |
GO:0007033 | vacuole organization | 1.500028e-3 |
GO:0016192 | vesicle-mediated transport | 1.527667e-3 |
GO:0006378 | mRNA polyadenylation | 1.544626e-3 |
GO:0051451 | myoblast migration | 1.548094e-3 |
GO:0019348 | dolichol metabolic process | 1.548094e-3 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 1.548094e-3 |
GO:0051254 | positive regulation of RNA metabolic process | 1.561029e-3 |
GO:0048711 | positive regulation of astrocyte differentiation | 1.563030e-3 |
GO:0046148 | pigment biosynthetic process | 1.612188e-3 |
GO:0048863 | stem cell differentiation | 1.614645e-3 |
GO:0035909 | aorta morphogenesis | 1.617764e-3 |
GO:0010611 | regulation of cardiac muscle hypertrophy | 1.630850e-3 |
GO:0001987 | vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure | 1.658832e-3 |
GO:0045818 | negative regulation of glycogen catabolic process | 1.658832e-3 |
GO:0072110 | glomerular mesangial cell proliferation | 1.672758e-3 |
GO:0060932 | His-Purkinje system cell differentiation | 1.689090e-3 |
GO:0060926 | pacemaker cell development | 1.689090e-3 |
GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 1.693124e-3 |
GO:0010942 | positive regulation of cell death | 1.720582e-3 |
GO:0032494 | response to peptidoglycan | 1.771740e-3 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 1.820345e-3 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 1.831162e-3 |
GO:0035269 | protein O-linked mannosylation | 1.831162e-3 |
GO:0033590 | response to cobalamin | 1.831162e-3 |
GO:0007144 | female meiosis I | 1.831162e-3 |
GO:0051148 | negative regulation of muscle cell differentiation | 1.831171e-3 |
GO:0060708 | spongiotrophoblast differentiation | 1.835000e-3 |
GO:0071044 | histone mRNA catabolic process | 1.847931e-3 |
GO:0051402 | neuron apoptosis | 1.893928e-3 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 1.893928e-3 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 1.906636e-3 |
GO:0031987 | locomotion involved in locomotory behavior | 1.906636e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 1.913873e-3 |
GO:0000910 | cytokinesis | 1.935770e-3 |
GO:0035404 | histone-serine phosphorylation | 2.092049e-3 |
GO:0046884 | follicle-stimulating hormone secretion | 2.092049e-3 |
GO:0032275 | luteinizing hormone secretion | 2.092049e-3 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 2.092049e-3 |
GO:0042471 | ear morphogenesis | 2.109910e-3 |
GO:0006783 | heme biosynthetic process | 2.124272e-3 |
GO:0055091 | phospholipid homeostasis | 2.140451e-3 |
GO:0009952 | anterior/posterior pattern specification | 2.147053e-3 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 2.152247e-3 |
GO:0090196 | regulation of chemokine secretion | 2.164422e-3 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 2.173929e-3 |
GO:0055006 | cardiac cell development | 2.206171e-3 |
GO:0060712 | spongiotrophoblast layer development | 2.214265e-3 |
GO:0022614 | membrane to membrane docking | 2.214265e-3 |
GO:0000189 | MAPK import into nucleus | 2.294598e-3 |
GO:0016568 | chromatin modification | 2.317959e-3 |
GO:2000696 | regulation of epithelial cell differentiation involved in kidney development | 2.320726e-3 |
GO:0014743 | regulation of muscle hypertrophy | 2.353431e-3 |
GO:0046777 | protein autophosphorylation | 2.366414e-3 |
GO:0046903 | secretion | 2.381706e-3 |
GO:2000648 | positive regulation of stem cell proliferation | 2.471898e-3 |
GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 2.491956e-3 |
GO:0072194 | kidney smooth muscle tissue development | 2.522625e-3 |
GO:0003270 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation | 2.522625e-3 |
GO:0014807 | regulation of somitogenesis | 2.522625e-3 |
GO:0042472 | inner ear morphogenesis | 2.523754e-3 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 2.565484e-3 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 2.565484e-3 |
GO:0035405 | histone-threonine phosphorylation | 2.565484e-3 |
GO:0040023 | establishment of nucleus localization | 2.602592e-3 |
GO:0015698 | inorganic anion transport | 2.614742e-3 |
GO:0042759 | long-chain fatty acid biosynthetic process | 2.630929e-3 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.704178e-3 |
GO:0051153 | regulation of striated muscle cell differentiation | 2.721188e-3 |
GO:0006650 | glycerophospholipid metabolic process | 2.749763e-3 |
GO:0090280 | positive regulation of calcium ion import | 2.757772e-3 |
GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 2.757772e-3 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.757772e-3 |
GO:0043297 | apical junction assembly | 2.820567e-3 |
GO:0006917 | induction of apoptosis | 2.827703e-3 |
GO:0003163 | sinoatrial node development | 2.831041e-3 |
GO:0051901 | positive regulation of mitochondrial depolarization | 2.831041e-3 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 2.832813e-3 |
GO:0032608 | interferon-beta production | 2.832813e-3 |
GO:0007089 | traversing start control point of mitotic cell cycle | 2.832813e-3 |
GO:0090066 | regulation of anatomical structure size | 2.846731e-3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 2.870443e-3 |
GO:0006325 | chromatin organization | 2.933925e-3 |
GO:0035904 | aorta development | 2.965913e-3 |
GO:0003161 | cardiac conduction system development | 2.973746e-3 |
GO:0007423 | sensory organ development | 2.993155e-3 |
GO:0006807 | nitrogen compound metabolic process | 2.996220e-3 |
GO:0060297 | regulation of sarcomere organization | 3.013291e-3 |
GO:0001655 | urogenital system development | 3.024173e-3 |
GO:0034394 | protein localization at cell surface | 3.073958e-3 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 3.096418e-3 |
GO:0006897 | endocytosis | 3.112727e-3 |
GO:0060920 | pacemaker cell differentiation | 3.117146e-3 |
GO:0007098 | centrosome cycle | 3.129508e-3 |
GO:0048469 | cell maturation | 3.150392e-3 |
GO:0006833 | water transport | 3.158134e-3 |
GO:0070972 | protein localization in endoplasmic reticulum | 3.166113e-3 |
GO:0008637 | apoptotic mitochondrial changes | 3.175660e-3 |
GO:0006505 | GPI anchor metabolic process | 3.207967e-3 |
GO:0010639 | negative regulation of organelle organization | 3.237639e-3 |
GO:0012502 | induction of programmed cell death | 3.270925e-3 |
GO:0010556 | regulation of macromolecule biosynthetic process | 3.297938e-3 |
GO:0042770 | signal transduction in response to DNA damage | 3.321412e-3 |
GO:0030216 | keratinocyte differentiation | 3.325327e-3 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 3.349901e-3 |
GO:0042310 | vasoconstriction | 3.361699e-3 |
GO:0060509 | Type I pneumocyte differentiation | 3.378177e-3 |
GO:0048280 | vesicle fusion with Golgi apparatus | 3.380015e-3 |
GO:0033299 | secretion of lysosomal enzymes | 3.380015e-3 |
GO:0006269 | DNA replication, synthesis of RNA primer | 3.380015e-3 |
GO:0060973 | cell migration involved in heart development | 3.381062e-3 |
GO:0021604 | cranial nerve structural organization | 3.381062e-3 |
GO:0034110 | regulation of homotypic cell-cell adhesion | 3.424808e-3 |
GO:0007009 | plasma membrane organization | 3.433493e-3 |
GO:0006189 | 'de novo' IMP biosynthetic process | 3.451361e-3 |
GO:0042440 | pigment metabolic process | 3.554289e-3 |
GO:0071870 | cellular response to catecholamine stimulus | 3.662920e-3 |
GO:0006281 | DNA repair | 3.747828e-3 |
GO:0050792 | regulation of viral reproduction | 3.819129e-3 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 3.865491e-3 |
GO:0060948 | cardiac vascular smooth muscle cell development | 3.879148e-3 |
GO:0043117 | positive regulation of vascular permeability | 3.879148e-3 |
GO:0019673 | GDP-mannose metabolic process | 3.879148e-3 |
GO:0051641 | cellular localization | 3.911283e-3 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.962600e-3 |
GO:0006497 | protein lipidation | 3.982220e-3 |
GO:0060284 | regulation of cell development | 4.047551e-3 |
GO:0071173 | spindle assembly checkpoint | 4.108905e-3 |
GO:0014741 | negative regulation of muscle hypertrophy | 4.108905e-3 |
GO:2000373 | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 4.155630e-3 |
GO:0017121 | phospholipid scrambling | 4.155630e-3 |
GO:0034340 | response to type I interferon | 4.155630e-3 |
GO:0043502 | regulation of muscle adaptation | 4.264432e-3 |
GO:0048318 | axial mesoderm development | 4.299089e-3 |
GO:0021569 | rhombomere 3 development | 4.299089e-3 |
GO:0042542 | response to hydrogen peroxide | 4.372560e-3 |
GO:0043154 | negative regulation of caspase activity | 4.438978e-3 |
GO:0042178 | xenobiotic catabolic process | 4.487419e-3 |
GO:0006355 | regulation of transcription, DNA-dependent | 4.488953e-3 |
GO:0002858 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 4.618358e-3 |
GO:0045596 | negative regulation of cell differentiation | 4.678585e-3 |
GO:0018209 | peptidyl-serine modification | 4.704435e-3 |
GO:0007088 | regulation of mitosis | 4.715945e-3 |
GO:0051494 | negative regulation of cytoskeleton organization | 4.759362e-3 |
GO:0051147 | regulation of muscle cell differentiation | 4.763279e-3 |
GO:0000920 | cytokinetic cell separation | 4.767523e-3 |
GO:0010604 | positive regulation of macromolecule metabolic process | 4.776744e-3 |
GO:0014031 | mesenchymal cell development | 4.844025e-3 |
GO:0090004 | positive regulation of establishment of protein localization in plasma membrane | 4.878521e-3 |
GO:0022603 | regulation of anatomical structure morphogenesis | 4.933946e-3 |
GO:0060460 | left lung morphogenesis | 4.950817e-3 |
GO:0035928 | rRNA import into mitochondrion | 4.950817e-3 |
GO:0014040 | positive regulation of Schwann cell differentiation | 4.950817e-3 |
GO:0035435 | phosphate ion transmembrane transport | 4.950817e-3 |
GO:0018202 | peptidyl-histidine modification | 4.975919e-3 |
GO:0030002 | cellular anion homeostasis | 4.986566e-3 |
GO:0021571 | rhombomere 5 development | 5.031762e-3 |
GO:0046013 | regulation of T cell homeostatic proliferation | 5.031762e-3 |
GO:0007352 | zygotic specification of dorsal/ventral axis | 5.031762e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 5.075445e-3 |
GO:0032862 | activation of Rho GTPase activity | 5.113524e-3 |
GO:0071695 | anatomical structure maturation | 5.192746e-3 |
GO:0060319 | primitive erythrocyte differentiation | 5.272394e-3 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 5.272394e-3 |
GO:0010159 | specification of organ position | 5.322643e-3 |
GO:0021960 | anterior commissure morphogenesis | 5.354270e-3 |
GO:0045685 | regulation of glial cell differentiation | 5.362624e-3 |
GO:0007062 | sister chromatid cohesion | 5.506800e-3 |
GO:0050434 | positive regulation of viral transcription | 5.610713e-3 |
GO:0032642 | regulation of chemokine production | 5.711440e-3 |
GO:0010468 | regulation of gene expression | 5.731621e-3 |
GO:0035767 | endothelial cell chemotaxis | 5.781480e-3 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 5.782762e-3 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 5.815302e-3 |
GO:0060556 | regulation of vitamin D biosynthetic process | 5.815302e-3 |
GO:0019987 | negative regulation of anti-apoptosis | 5.815302e-3 |
GO:0006613 | cotranslational protein targeting to membrane | 5.815302e-3 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 5.841908e-3 |
GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure | 5.915972e-3 |
GO:0007389 | pattern specification process | 5.924119e-3 |
GO:0072089 | stem cell proliferation | 5.967431e-3 |
GO:0090010 | transforming growth factor beta receptor signaling pathway involved in primitive streak formation | 5.967431e-3 |
GO:0060802 | epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification | 5.967431e-3 |
GO:0048327 | axial mesodermal cell fate specification | 5.967431e-3 |
GO:0006552 | leucine catabolic process | 5.967431e-3 |
GO:0030844 | positive regulation of intermediate filament depolymerization | 5.967431e-3 |
GO:0002085 | inhibition of neuroepithelial cell differentiation | 5.967431e-3 |
GO:0032814 | regulation of natural killer cell activation | 6.128641e-3 |
GO:0042267 | natural killer cell mediated cytotoxicity | 6.176382e-3 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 6.290221e-3 |
GO:0043583 | ear development | 6.389937e-3 |
GO:0090307 | spindle assembly involved in mitosis | 6.407851e-3 |
GO:0021612 | facial nerve structural organization | 6.407851e-3 |
GO:0048319 | axial mesoderm morphogenesis | 6.407851e-3 |
GO:0042168 | heme metabolic process | 6.470550e-3 |
GO:0060977 | coronary vasculature morphogenesis | 6.659235e-3 |
GO:0048762 | mesenchymal cell differentiation | 6.701715e-3 |
GO:0035886 | vascular smooth muscle cell differentiation | 6.731478e-3 |
GO:0031577 | spindle checkpoint | 6.786952e-3 |
GO:0000460 | maturation of 5.8S rRNA | 6.786952e-3 |
GO:0051693 | actin filament capping | 6.861978e-3 |
GO:0014910 | regulation of smooth muscle cell migration | 6.938919e-3 |
GO:0072017 | distal tubule development | 7.018363e-3 |
GO:0072193 | ureter smooth muscle cell differentiation | 7.021606e-3 |
GO:0031579 | membrane raft organization | 7.090824e-3 |
GO:0016074 | snoRNA metabolic process | 7.090824e-3 |
GO:0002076 | osteoblast development | 7.158266e-3 |
GO:2001020 | regulation of response to DNA damage stimulus | 7.161298e-3 |
GO:2000243 | positive regulation of reproductive process | 7.213006e-3 |
GO:0072104 | glomerular capillary formation | 7.335732e-3 |
GO:0048864 | stem cell development | 7.480714e-3 |
GO:0045837 | negative regulation of membrane potential | 7.507798e-3 |
GO:0042552 | myelination | 7.579296e-3 |
GO:0061004 | pattern specification involved in kidney development | 7.584601e-3 |
GO:0019827 | stem cell maintenance | 7.615405e-3 |
GO:0006402 | mRNA catabolic process | 7.652743e-3 |
GO:0006887 | exocytosis | 7.673840e-3 |
GO:0006474 | N-terminal protein amino acid acetylation | 7.688171e-3 |
GO:0072078 | nephron tubule morphogenesis | 7.860693e-3 |
GO:0043254 | regulation of protein complex assembly | 7.892249e-3 |
GO:0009650 | UV protection | 7.916638e-3 |
GO:0031333 | negative regulation of protein complex assembly | 7.924106e-3 |
GO:0032816 | positive regulation of natural killer cell activation | 7.981350e-3 |
GO:0045955 | negative regulation of calcium ion-dependent exocytosis | 8.028080e-3 |
GO:0030730 | sequestering of triglyceride | 8.028080e-3 |
GO:0043010 | camera-type eye development | 8.306526e-3 |
GO:0034767 | positive regulation of ion transmembrane transport | 8.399102e-3 |
GO:0060840 | artery development | 8.401860e-3 |
GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 8.530106e-3 |
GO:0042633 | hair cycle | 8.572266e-3 |
GO:0051493 | regulation of cytoskeleton organization | 8.594372e-3 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 8.605063e-3 |
GO:0001837 | epithelial to mesenchymal transition | 8.662890e-3 |
GO:0042157 | lipoprotein metabolic process | 8.722451e-3 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 8.788714e-3 |
GO:0072215 | regulation of metanephros development | 8.802685e-3 |
GO:0071436 | sodium ion export | 8.935983e-3 |
GO:0071479 | cellular response to ionizing radiation | 8.979698e-3 |